Screener
Tango Therapeutics TNGX Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 7) | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | — | — |
| Stockholders' equity: | ||
| Common stock, $0.001 par value; 400,000,000 and 200,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 144,162,543 and 135,940,454 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 144 | 136 |
| Additional paid-in capital | 1,040,143 | 948,971 |
| Accumulated other comprehensive (loss) income | (115) | 224 |
| Accumulated deficit | (648,666) | (603,152) |
| Total stockholders’ equity | 391,506 | 346,179 |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's common stock par value per share?
- Tango Therapeutics (TNGX) reported common stock par value per share of $0.00 in Q1 2026.
- How has Tango Therapeutics's common stock par value per share changed year-over-year?
- Tango Therapeutics's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Tango Therapeutics's common stock par value per share?
- Over 5 years (2020 to 2025), Tango Therapeutics's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Tango Therapeutics's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude